Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib in Recurrent Malignant Glioma
NCT00005859Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- May 2000
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in malignant glioma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started May 2000; status: completed.
02
Drugs
tipifarnib
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00005859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005859.